Population pharmacokinetics

Population pharmacokinetics

Saved in:

Bibliographic Details
Main Authors:	Milovanović Jasmina R., Janković Slobodan M.
Format:	Article
Language:	English
Published:	Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2005-01-01
Series:	Vojnosanitetski Pregled
Subjects:	pharmacokinetics population dose-response relationship drug software
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500511847M.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Population Pharmacokinetic Model to Inform Extension of the Eteplirsen Dosing Regimen Across the Broad DMD Population
by: Yogesh Patel, et al.
Published: (2025-05-01)

Population Pharmacokinetic and Exposure–Response Analyses for Ponatinib in the Phase 3 PhALLCON Study
by: Michael J. Hanley, et al.
Published: (2025-03-01)

Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients
by: Xiping Li, et al.
Published: (2024-08-01)

Parametric Population Pharmacokinetics Model Repository of Rifampicin: Model-Informed Individualized Therapy
by: Ju G, et al.
Published: (2025-04-01)

Population pharmacokinetics of colistin sulfate in critically ill patients based on NONMEM
by: Qiang Sun, et al.
Published: (2025-05-01)

Optimizing Lidocaine Dosing in Hepatectomy Patients: A Population Pharmacokinetic Study of Active Metabolites
by: He C, et al.
Published: (2025-07-01)

A pharmacokinetic comparison of three pharmaceutical formulations of nimesulide in healthy volunteers
by: Jovanović Dušan, et al.
Published: (2005-01-01)

Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients
by: Jing Wang, et al.
Published: (2025-01-01)

Corrigendum: Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients
by: Jing Wang, et al.
Published: (2025-02-01)

Open label, dose escalation trial of creatine monohydrate in pregnancy
by: Madison Naidu, et al.
Published: (2025-09-01)

Influential predictors of azithromycin pharmacokinetics: a systematic review of population pharmacokinetics
by: Janthima Methaneethorn, et al.
Published: (2025-12-01)

Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation
by: Sílvia M. Illamola, et al.
Published: (2025-05-01)

Population pharmacokinetics and dose optimization of ceftazidime in critically ill children
by: Mengting Li, et al.
Published: (2024-11-01)

The Effect of Drug&ndash;Drug Interactions on the Pharmacokinetics of Isavuconazole: A Comprehensive Review
by: Sang Y, et al.
Published: (2025-06-01)

Dosing Regimen Recommendations for Sirolimus in Adult Liver Transplant Recipients: Insights from a Population Pharmacokinetic Model
by: Mao J, et al.
Published: (2024-12-01)

Investigating Remedial Strategies for Missed or Delayed Dose of Sertraline in Chinese Adolescent Patients with Depressive Disorders via Population Pharmacokinetics Modeling and Simulation Approaches
by: Xia H, et al.
Published: (2025-04-01)

Population Pharmacokinetics and Exposure–Response Relationships of Maribavir in Transplant Recipients With First Episode or Refractory Cytomegalovirus
by: Kefeng Sun, et al.
Published: (2025-08-01)

Population pharmacokinetics of polymyxin B in critically ill patients with carbapenem-resistant organisms infections: insights from steady-state trough and peak plasma concentration
by: Jun Yang, et al.
Published: (2025-03-01)

External validation of population pharmacokinetic models for meropenem in critically ill adult patients
by: Carla Bastida, et al.
Published: (2025-06-01)

Middle‐Out Physiologically Based Pharmacokinetic Modeling to Support Pediatric Dosing Recommendation for Alectinib
by: Tamara vanDonge, et al.
Published: (2025-06-01)

Machine learning and population pharmacokinetics: a hybrid approach for optimizing vancomycin therapy in sepsis patients
by: Keyu Chen, et al.
Published: (2025-05-01)

Significant Predictors of Azithromycin in Population Pharmacokinetic Analysis: A Systematic Review
by: Zhang R, et al.
Published: (2025-07-01)

Population Pharmacokinetic Modeling of Total and Unbound Pamiparib in Glioblastoma Patients: Insights into Drug Disposition and Dosing Optimization
by: Charuka Wickramasinghe, et al.
Published: (2025-04-01)

Development and Validation of a Population Pharmacokinetics Model of Perampanel for Pediatric Epilepsy Patients for Optimized Dosing
by: Yu L, et al.
Published: (2025-04-01)

Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies
by: Luisa Oliveira Santos, et al.
Published: (2024-08-01)

Population Pharmacokinetics and Model-Informed Precision Dosing of Clobazam Based on the Developmental and Genetic Characteristics of Children with Epilepsy
by: Yali Tuo, et al.
Published: (2025-06-01)

Population pharmacokinetics of vancomycin in non-extremely preterm neonates based on real-world studies: influence of daily fluid input and diuretics
by: Kai Zhao, et al.
Published: (2025-06-01)

<i>ABCB1</i> Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
by: Natasa Djordjevic, et al.
Published: (2025-01-01)

Establishment and application of population pharmacokinetics model of vancomycin in infants with meningitis
by: Jianwen Xu, et al.
Published: (2022-01-01)

Multidose Dalbavancin Population Pharmacokinetic Analysis for Prolonged Target Attainment in Patients Requiring Long-Term Treatment
by: Giammarco Baiardi, et al.
Published: (2025-02-01)

Drug Dosing in Pediatrics: Possible Approaches
by: Alexey S. Kolbin, et al.
Published: (2023-08-01)

Establishment and validation of a population pharmacokinetic model for apatinib in patients with tumors
by: Li’an Zuo, et al.
Published: (2024-11-01)

Drug-drug interaction of paroxetine on olanzapine and initial dosage optimization in patients with major depressive disorder based on population pharmacokinetics
by: Cun Zhang, et al.
Published: (2025-05-01)

Physiologically Based Pharmacokinetic Modeling to Predict Lamotrigine Exposure in Special Populations to Facilitate Therapeutic Drug Monitoring and Guide Dosing Regimens
by: Ji-Cheng Li, et al.
Published: (2025-04-01)

Population-pharmacokinetic/pharmacodynamic model of atractylodes lancea (Thunb.) DC. administration in patients with advanced-stage intrahepatic cholangiocarcinoma: a dosage prediction
by: Teerachat Saeheng, et al.
Published: (2024-11-01)

Adverse effects of long term, continual administration of high doses of albendazole in the treatment of echinococcal disease
by: Jevtić Miodrag, et al.
Published: (2008-01-01)

A Population Pharmacokinetics Study of Venetoclax Concomitant with Voriconazole in Patients with Hematologic Malignancies
by: Yang J, et al.
Published: (2025-05-01)

Push Forward Clinical Management of Hematological Toxicity due to Lenalidomide Overexposure: Model‐Informed Precision Dosing for Chinese Population With Renal Insufficiency
by: Yi Ma, et al.
Published: (2025-07-01)

Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics
by: Haruno Oku, BS, et al.
Published: (2025-01-01)

Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation
by: Todd A. Miano, PharmD, PhD, et al.
Published: (2024-11-01)